• Olga Fedorova
  • Viktoria Nikolaeva
  • Raisa Krasikova

[18F]fluoroestradiol ([18F]FES) is well-established PET radiotracer for diagnosing and monitoring treatment of estrogen-positive breast cancer. The radiotracer is produced via one-pot two steps synthesis using cyclic sulfate precursor and is usually purified by semi-preparative HPLC. Here we suggested simple SPE purification procedure using OASIS WAX 3cc and Sep-Pak QMA light cartridges that afforded [18F]FES in typically 15% RCY (corrected for decay) within 45 min formulated in 5% EtOH/saline. All purity parameters were well within specifications recommended in the Investigator's Brochure for [18F]Fluoroestradiol.

Original languageEnglish
Pages (from-to)57-63
Number of pages7
JournalApplied Radiation and Isotopes
Volume141
DOIs
StatePublished - Nov 2018

    Scopus subject areas

  • Chemistry(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

    Research areas

  • 16α-[F]fluoroestradiol, Estrogen receptor, Fluorine-18, PET, SPE purification, [F]FES, 16α-[18F]fluoroestradiol, [18F]FES, BREAST-CANCER, ESTROGEN-RECEPTORS, F-18-FLUOROESTRADIOL, 16 alpha-[F-18]fluoroestradiol [F-18]FEs

ID: 35115482